Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
Galadanci AA, Galadanci NA, Jibir BW, Abdullahi SU, Idris N, Gambo S, Ali Abubakar SA, Kabo NA, Bello-Manga H, Haliru L, Bashir I, Aliyu MH, Galadanci JA, DeBaun MR. Galadanci AA, et al. Among authors: gambo s. Am J Hematol. 2019 Nov;94(11):E305-E307. doi: 10.1002/ajh.25616. Epub 2019 Sep 11. Am J Hematol. 2019. PMID: 31423630 Free PMC article. No abstract available.
World Health Organization's Growth Reference Overestimates the Prevalence of Severe Malnutrition in Children with Sickle Cell Anemia in Africa.
Ghafuri DL, Abdullahi SU, Jibir BW, Gambo S, Bello-Manga H, Haliru L, Bulama K, Usman FM, Gambo A, Aliyu MH, Greene BC, Kassim AA, Slaughter C, Rodeghier M, DeBaun MR. Ghafuri DL, et al. Among authors: gambo s, gambo a. J Clin Med. 2020 Jan 2;9(1):119. doi: 10.3390/jcm9010119. J Clin Med. 2020. PMID: 31906442 Free PMC article.
Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
Bello-Manga H, Galadanci AA, Abdullahi S, Ali S, Jibir B, Gambo S, Haliru L, Jordan LC, Aliyu MH, Rodeghier M, Kassim AA, DeBaun MR, Galadanci NA. Bello-Manga H, et al. Among authors: gambo s. Br J Haematol. 2020 Sep;190(6):939-944. doi: 10.1111/bjh.16746. Epub 2020 May 16. Br J Haematol. 2020. PMID: 32415792 Free PMC article. Clinical Trial.
Primary prevention of stroke in children with sickle cell anemia in sub-Saharan Africa: rationale and design of phase III randomized clinical trial.
Abdullahi SU, Wudil BJ, Bello-Manga H, Musa AB, Gambo S, Galadanci NA, Aminu H, Tijjani Gaya A, Sanusi S, Tabari MA, Galadanci A, Borodo A, Abba MS, Dambatta AH, Haliru L, Gambo A, Cassell H, Rodeghier M, Ghafuri DL, Covert Greene BV, Neville K, Kassim AA, Kirkham F, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Among authors: gambo s, gambo a. Pediatr Hematol Oncol. 2021 Feb;38(1):49-64. doi: 10.1080/08880018.2020.1810183. Epub 2020 Nov 25. Pediatr Hematol Oncol. 2021. PMID: 33236662 Free PMC article. Clinical Trial.
Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.
Ghafuri DL, Abdullahi SU, Dambatta AH, Galadanci J, Tabari MA, Bello-Manga H, Idris N, Inuwa H, Tijjani A, Suleiman AA, Jibir BW, Gambo S, Gambo AI, Khalifa Y, Haliru L, Abdulrasheed S, Zakari MA, Greene BC, Trevathan E, Jordan LC, Aliyu MH, Baumann AA, DeBaun MR. Ghafuri DL, et al. Among authors: gambo s, gambo ai. J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e56-e61. doi: 10.1097/MPH.0000000000002179. J Pediatr Hematol Oncol. 2022. PMID: 34001783 Free PMC article. Clinical Trial.
Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.
Ghafuri DL, Covert Greene B, Musa B, Gambo A, Sani A, Abdullahi S, Wudil BJ, Bello-Manga H, Gambo S, Ghafuri M, Cassell H, Neville K, Kirkham F, Kassim AA, Aliyu MH, DeBaun MR, Jordan LC. Ghafuri DL, et al. Among authors: gambo s, gambo a. Pediatr Neurol. 2021 Dec;125:9-15. doi: 10.1016/j.pediatrneurol.2021.08.010. Epub 2021 Sep 4. Pediatr Neurol. 2021. PMID: 34563875 Free PMC article. Clinical Trial.
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trial.
Abdullahi SU, Jibir BW, Bello-Manga H, Gambo S, Inuwa H, Tijjani AG, Idris N, Galadanci A, Hikima MS, Galadanci N, Borodo A, Tabari AM, Haliru L, Suleiman A, Ibrahim J, Greene BC, Ghafuri DL, Rodeghier M, Slaughter JC, Kirkham FJ, Neville K, Kassim A, Trevathan E, Jordan LC, Aliyu MH, DeBaun MR. Abdullahi SU, et al. Among authors: gambo s. Lancet Haematol. 2022 Jan;9(1):e26-e37. doi: 10.1016/S2352-3026(21)00368-9. Lancet Haematol. 2022. PMID: 34971579 Free PMC article. Clinical Trial.
Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial.
Abdullahi SU, Sunusi S, Abba MS, Sani S, Inuwa HA, Gambo S, Gambo A, Musa B, Covert Greene BV, Kassim AA, Rodeghier M, Hussaini N, Ciobanu M, Aliyu MH, Jordan LC, DeBaun MR. Abdullahi SU, et al. Among authors: gambo s. Blood. 2023 Feb 23;141(8):825-834. doi: 10.1182/blood.2022016620. Blood. 2023. PMID: 36322937 Free PMC article. Clinical Trial.
29 results